Drug Profile
Research programme: human papillomavirus vaccine - 3SBio
Alternative Names: SSS 08Latest Information Update: 16 Feb 2017
Price :
$50
*
At a glance
- Originator 3SBio
- Class Papillomavirus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cervical cancer; Human papillomavirus infections
Most Recent Events
- 16 Feb 2017 Discontinued - Preclinical for Cervical cancer (Prevention) in China (Parenteral)
- 16 Feb 2017 Discontinued - Preclinical for Human papillomavirus infections (Prevention) in China (Parenteral)
- 04 Dec 2007 Preclinical trials in Cervical cancer in China (Parenteral)